Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omeros Corp (NQ: OMER )

2.705 +0.175 (+6.92%)
Streaming Delayed Price Updated: 3:33 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 283,287
Open 2.550
Bid (Size) 2.700 (4)
Ask (Size) 2.710 (8)
Prev. Close 2.530
Today's Range 2.520 - 2.705
52wk Range 1.735 - 7.750
Shares Outstanding 62,730,015
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga

Performance

YTD
+9.07%
+9.07%
1 Month
+19.69%
+19.69%
3 Month
-20.21%
-20.21%
6 Month
-39.49%
-39.49%
1 Year
-49.34%
-49.34%

More News

Read More
US Stocks Open Lower; Dow Falls Over 100 Points
Via Benzinga
UBS Downgrades Omeros: Here's What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Canoo Shares Are Trading Higher By Over 12%? Here Are 32 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
US Stocks Mixed On Black Friday; Dow Rises Over 100 Points
Via Benzinga
Omeros Corporation Reports Third Quarter 2022 Financial Results
From Omeros Corporation
Via Business Wire
Preview: Omeros's Earnings
Via Benzinga
Omeros Corporation Receives Decision from FDA on Formal Dispute Resolution Request for Narsoplimab
From Omeros Corporation
Via Business Wire
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2022
From Omeros Corporation
Via Business Wire
Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
From Omeros Corporation
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Peering Into Omeros's Recent Short Interest
Via Benzinga
Omeros Corporation Announces Royalty Monetization Transaction with DRI Healthcare Trust
From Omeros Corporation
Via Business Wire
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
Via Benzinga
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
Via Benzinga
Analyzing Omeros's Short Interest
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Omeros COVID-19 Treatment Reduced Mortality Risk, But Biased Data Rendered Analysis Meaningless
Via Benzinga
US Stocks Gain Following Economic Data; Dow Jumps Over 100 Points
Via Benzinga
Omeros Corporation Reports Narsoplimab Treatment Results in Critically Ill COVID-19 Patients in I-SPY COVID Trial
From Omeros Corporation
Via Business Wire
I-SPY COVID Trial Sponsored by Quantum Leap Healthcare Collaborative Reports Assessment of Narsoplimab for Treatment of Critically Ill Patients With COVID-19
From Quantum Leap Healthcare Collaborative and Omeros Corporation
Via Business Wire
Advance Auto Parts, Nordstrom And Other Big Stocks Recording Losses On Wednesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.